Mortality in People Taking Selegiline:Observational Study
BMJ 317:252-254, Thorogood,M.,et al, 1998
Managing the Neuropsychiatric Symptoms of Parkinson's Disease
Neurol 50:S33-S38, Lieberman,A., 1998
Investig of PDRG of UK into Excess Mortality Seen/Comb Levodopa & Selegiline Trmt in Pts with Early, Mild Parkinson's Dis
BMJ 316:1191-1196, Ben-Shlomo,Y.,et al, 1998
Functional Neurosurgery for parkinson's Disease, Has Come a Long Way, Though Much Remains Experimental
BMJ 316:1259-1260, Quinn,N.&Bhatia,K., 1998
Pallidotomy for Parkinson's Disease:Hitting the Target
Lancet 351:998-999, Golbe,L.I., 1998
Neuropsychological Consequences of Posteroventral Pallidotomy for the Treatment of Parkinson's Disease
Neurol 51:207-215, Trepanier,L.L.,et al, 1998
Cognitive Functioning After Pallidotomy for Refractory Parkinson's Disease
JNNP 65:150-154, 1481998., Perrine,K.,et al, 1998
Olanzapine Can Worsen Parkinsonism
Neurol 50:1183-1184, Jimenez-Jimenez,F.J.,et al, 1998
Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 50:1195-1196, Wolters,E.C.,et al, 1998
Tolcapone for Parkinson's Disease
The Medical Letter 40:60-61, , 1998
Random, Placebo-Contr Study of Tolcapone in Pts with Fluctuating Parkinson Dis Trtd With Levodopa-Carbidopa
Arch Neurol 55:1089-1095, Adler,C.H.,et al, 1998
Catechol-O-Methyltransferase Inhibitors for Treatment of Parkinson's Disease
Lancet 351:1221-1222, Nutt,J.G., 1998
Hematopoietic Stem-Cell Transplantation in Globoid-Cell Leukodystrophy
NEJM 338:1119-1126, Krivit,W.,et al, 1998
Mucolipidosis Type IV; Characteristic MRI Findings
Neurol 51:565-569, Frei,K.P.,et al, 1998
Clinicopath Conf
Demyelinating Process Consistent with Multiple Sclerosis, Case 26-1998, NEJM 339:542-549998., , 1998
Clinical Usefulness of Magnetic Resonance Imaging in Multiple System Atrophy
JNNP 65:65-71, Schrag,A.,et al, 1998
Drug-Induced Movement Disorders
Neurol Clin 16:125-139, Diederich,N.J. & Goetz,C.G., 1998
Subdural Haemorrhages in Infants:Population Based Study
BMJ 317:1558-1561,1538, Jayawant,S.,et al, 1998
Pallidotomy for Generalized Dystonia
Movement Disorders 13:693-698, Ondo,W.G.,et al, 1998
Isolated Vagal Nerve Palsy Associated with a Dissection of the Extracranial Internal Carotid Artery
AJNR 19:1845-1847, Nusbaum, A.O.,et al, 1998
Magnetic Resonance Imaging Features of Solitary Inflammatory Brain Masses
J Neuroimag 8:8-14, Bakshi,R.,et al, 1998
Permanent Visual Loss and Cerebrovascular Accidents in Giant Cell Arteritis: Predictors and Response to Treatment
Arthritis Rheum 41:1497-1504, Gonzalez-Gay,M.,et al, 1998
Subcotical Arteriosclerotic Encephalopathy (Binswangers Disease)
, Ghika,J. &Bogousslavsky, J., 1998
Posterior Cerebral Artery Syndromes
, Caplan,L.R. &Bogousslavsky,J., 1998
Spontaneous Intracranial Hypotension: Clinical and Magnetic Resonance Imaging
Clin Neurol Neurosurg 99:199-204, Blank,S.C., et al, 1997
Vasculitis and Relate Disorders
In Textbook of Rheumatology, W.B. Saunders Co, 5th Ed, Chp 68, 1088, Valente,R.M.,et al, 1997
Bilirubin Metabolism and Kernicterus
Adv Pediatr 44:173-229, Gourley,G.R., 1997
Complications of Transsphenoidal Surgery:Results of a National Survey, Review of the Literature, and Personal Experience
Neurosurg 40:225-236, Ciric,I.,et al, 1997
Extrapyramidal Side Effects with Low-Dose Risperidone
Can J Psychiatry 42:325-325, Brown, E.S., 1997
Unilateral Pallidotomy for Parkinson's Disease:Comparison of Outcome in Yonger Vs Elderly Patients
Neurol 49:1072-1077, Uitti,R.J.,et al, 1997
Posteroventral Medial Pallidotomy in Advanced Parkinson's Disease
NEJM 337:1036-1042, Lang,A.E.,et al, 1997
Chemosensory Event-Related Potentials in Response to Trigeminal & Olfactory Stim in Idio Parkinson's Dis
Neurol 49:1424-1431, Barz,S.,et al, 1997
Olfactory Dysfunction in Familial Parkinsonism
Neurol 49:1262-1267, Markopoulou,K.,et al, 1997
Smoking and Parkinson's Disease, An Age-Dependent Risk Effect
Neurol 49:1267-1272, Tzourio,C.,et al, 1997
Clozapine in Parkinson's Disase Tremor, Effets of Acute and Chronic Administration
Neurol 49:1587-1590, Bonuccelli,U.,et al, 1997
The 5-Year Risk of MS After Optic Neuritis
Experience of the Optic Neuritis Trtm Trial, Optic Neuritis Study Group, Neurol 49:1404-1413997., , 1997
Risk Factors for Developing Multiple Sclerosis after Childhood Optic Neuritis
Neurol 49:11413-1418, Lucchinetti,C.F.,et al, 1997
Hemiparetic Acute Myopathy of Intensive Care Progressing to Triplegia
Arch Neurol 54:1420-1422, Sun,D.Y.,et al, 1997
Optic Nerve Sheath Fenestration for Pseudotumor Cerebri
J Neuro-Ophthalmol 17:86-91, Goh,K.Y.,et al, 1997
Pallidal Stimulation for Parkinson's Disease, Two Targets
Neurol 49:1564-1569, Bejjani,B.,et al, 1997
Frontotemporal Degeneration, Pick Disease, and Corticobasal Degeneration
Arch Neurol 54:1425-1427, 14291997., Neary,D., 1997
Frontotemporal Dementia, Pick Disease, and Corticobasal Degeneration
Arch Neurol 54:1427-1429, Kertesz,A., 1997
Treatment of Gustatory Sweating with Botulinum Toxin
Ann Neurol 42:973-975, Naumann,M.,et al, 1997
Neuroimaging in Presumed Primary Headache Disorders
Semin Neurol 17:373-382, Frishberg,B.M., 1997
Unilateral Hypnic Headache:A Case Study
Neurol 49:1749-1751, Gould,J.D.&Silberstein,S.D., 1997
Ocular Findings in Ramsay Hunt Syndrome
J Neuro-Ophthalmol 17:199-201, Mansour,A.M.&Bailey,B.J., 1997
Complete Ophthalmoplegia After Zoster Ophthalmicus
J Neuro-Ophthalmol 17:262-265, Chang-Godinich,A.,et al, 1997
Pallidotomy for Hemiballismus:Efficacy and Characteristics of NEuronal Activity
Ann Neurol 42:807-811, Suarez,J.I.,et al, 1997
Cabergoline Treatment of Early Parkinson's Disease:First Yr of Trtm Comparison of Cabergoline & Levodopa
Neurol 48:363-368, Rinne,U.K.,et al, 1997
Proton Magnetic Resonance Spectroscopy in Parkinson's Disease and Progressive Supranuclear Palsy
JNNP 62:239-242, Federico,F.,et al, 1997